Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 1, 2004; 10(5): 649-653
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649
Table 5 Hepatocellular carcinoma stage and survival time, CLIP classification and survival time
| Group | Score | |||||||
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | ||
| A (n = 20) | Case | 0 | 2 | 2 | 2 | 8 | 5 | 1 |
| Survival days | 220.5 | 49 | 42 | 35 | 12.3 | 11 | ||
| B (n = 76) | Case | 1 | 8 | 20 | 20 | 15 | 9 | 3 |
| Survival days | > 345 | 301 | 150.5 | 106.8 | 96.2 | 59.5 | 19.3 | |
- Citation: Wang TE, Kao CR, Lin SC, Chang WH, Chu CH, Lin J, Hsieh RK. Salvage therapy for hepatocellular carcinoma with thalidomide. World J Gastroenterol 2004; 10(5): 649-653
- URL: https://www.wjgnet.com/1007-9327/full/v10/i5/649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i5.649